MetaCap

AirSculpt Technologies (AIRS) vs LifeMD (LFMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

LifeMD (LFMD) has outperformed AirSculpt Technologies (AIRS) over the past year, losing 62.5% versus a loss of 83.9%. Over five years, LFMD leads with a -65.9% price change compared with -95.1% for AIRS. LifeMD is the larger company by market cap ($69.8 million vs $43.7 million), about 1.6 times the size.

LifeMD converts more of its revenue into profit, with a net margin of 7.4% versus -7.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AIRS-83.86%LFMD-62.47%
+63%-15%-92%
Nov 21, 20251 yearNov 20, 2026
AIRS-96.04%LFMD-68.17%
+241%+64%-113%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AIRS versus LFMD key metrics
MetricAIRSLFMD
Share price$0.5907$1.45
Market cap$43.67M$69.84M
1-day change-9.72%-9.40%
YTD return-70.17%-57.62%
1-year return-83.86%-62.47%
5-year return-95.10%-65.92%
Forward P/E—9.32
EPS (TTM)$-0.12$-0.52
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$151.82M$194.06M
Revenue growth (YoY)-15.82%+25.34%
Net income (latest FY)$-11.67M$14.35M
Gross margin59.37%85.72%
Operating margin-7.61%-3.95%
Net margin-7.68%7.40%
52-week high$5.79$5.38
52-week low$0.516$1.38
Distance from 52-week high-89.80%-73.14%
Analyst consensusnonestrong_buy
Avg. price target upside+661.81%+462.63%
Average volume1.27M929.40K
Shares outstanding73.93M48.33M
Employees330347
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • LFMD has outperformed AIRS by 21.4 percentage points over the past year.
  • LifeMD is more profitable, keeping 7.4 cents of every revenue dollar as net income versus -7.7 cents for AirSculpt Technologies.
  • LifeMD grew revenue faster in its latest fiscal year (+25.34% vs -15.82%).

About AirSculpt Technologies

AIRS stock →

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.

Health Care · Medical/Nursing Services · 330 employees

About LifeMD

LFMD stock →

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.

Health Care · Medical/Nursing Services · 347 employees

AIRS vs LFMD FAQ

Which is bigger, AirSculpt Technologies or LifeMD?

LifeMD (LFMD) is larger, with a market capitalization of $69.84M compared with $43.67M for AirSculpt Technologies (AIRS).

Which stock has performed better over the past year, AIRS or LFMD?

LFMD returned -62.47% over the past 12 months, compared with -83.86% for AIRS (price return, excluding dividends). Past performance does not predict future results.

Are AirSculpt Technologies and LifeMD in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons